Abstract
Acetaldehyde (AcH) produced in the physiological metabolism of ethanol can be potentially toxic and immunomodulating. The antitumour activity of a suicide gene system using adenovirus delivered alcohol dehydrogenase (ADH) to convert ethanol to acetaldehyde inside cancer cells has been investigated in vitro and in vivo. In vitro experiments confirmed the toxicity of acetaldehyde to a number of tumour cell lines. Daudi lymphoma cells grown in normal media increased by Day 4 to 650% of their starting number, while those exposed to 250 μM, 500 μM and 1 mM acetaldehyde reached 138, 30 and 5% respectively. Adenocarcinoma cells appeared to be less sensitive with CMT-64 cells and HeLa cells numbering 105 and 53% of their starting number by Day 4 with 1 mM acetaldehyde. After transduction with an adenovirus containing the human ADH beta 2 cDNA, CMT-64 cells exposed to 20 mM ethanol had a reduction in number to 74% by Day 2 and to 36% by Day 4. In a preclinical model with Ad-ADH CMT-64 cells, mice exposed to daily pulses of ethanol for 5 days formed tumours only 30% on Day 6 and 42% on Day 13 of the volume of those in mice exposed to water.The ability of this easily administered suicide gene system to produce significant effects on cell proliferation in vivo suggests that further optimized development is warranted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Xu G, McLeod HL . Strageties for enzyme/prodrug cancer therapy. Clin Cancer Res. 2001;7:3314–3324.
Bridgewater JA, Springer CJ, Knox RJ, et al. Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954. Eur J Cancer. 1995;31A:2362–2370.
Huber BE, Austin EA, Good SS, et al. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 1993;53:4619–4626.
Greco O, Folkes LK, Wardman P, et al. Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther. 2000;7:1414–1420.
Moolten FL, Wells JM . Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst. 1990;82:297–300.
Chen L, Waxman DJ . Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy. Cancer Res. 1995;55:581–589.
Singh NP, Khan A . Acetaldehyde: genotoxicity and cytotoxicity in human lymphocytes. Mutat Res. 1995;337:9–17.
Terabayashi H, Kolber MA . The generation of cytotoxic T lymphocytes against acetaldehyde-modified syngeneic cells. Alcohol Clin Exp Res. 1990;14:893–899.
Higgins PJ, Borenfreund E . Incubation of rat hepatic tumor cells with ethanol and acetaldehyde in vitro: effects on growth rate, albumin secretion and cellular protein content. Digestion. 1986;34:161–168.
Clemens DL, Forman A, Jerrells TR, et al. Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology. 2002;35:1196–1204.
Clemens DL, Calisto LE, Sorrell MF, et al. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells. Hepatology. 2003;38:385–393.
Liang Q, Carlson EC, Borgerding AJ, et al. A transgenic model of acetaldehyde overproduction accelerates alcohol cardiomyopathy. J Pharmacol Exp Ther. 1999;291:766–772.
Hurley TD, Edenberg HJ, Li T-K . The pharmacogenomics of alcoholism. In: Pharmacogenomics: The Search for Individualized Therapeutics. Licinio J, Wong M-L, eds. Weinheim: Wiley-VCH; 2002: 417–442.
Kitson KE . Ethanol and acetaldehyde metabolism: past, present, and future. Alcohol Clin Exp Res. 1996;20:82A–92A.
Wickramasinghe SN, Malik F . Acetaldehyde causes a prolongation of the doubling time and an increase in the modal volume of cells in culture. Alcohol Clin Exp Res. 1986;10:350–354.
Koivisto T, Salaspuro M . Acetaldehyde alters proliferation, differentiation and adhesion properties of human colon adenocarcinoma cell line Caco-2. Carcinogenesis. 1998;19:2031–2036.
Mapoles JE, Iwahashi M, Lucas D, et al. Acetaldehyde exposure causes growth inhibition in a Chinese hamster ovary cell line that expresses alcohol dehydrogenase. Alcohol Clin Exp Res. 1994;18:632–639.
Holownia A, Ledig M, Mapoles J, et al. Acetaldehyde-induced growth inhibition in cultured rat astroglial cells. Alcohol. 1996;1:93–97.
Zimmerman BT, Crawford GD, Dahl R, et al. Mechanisms of acetaldehyde-mediated growth inhibition: delayed cell cycle progression and induction of apoptosis. Alcohol Clin Exp Res. 1995;19:434–440.
Stone CL, Bosron WF, Dunn MF . Amino acid substitutions at position 47 of human beta 1 beta 1 and beta 2 beta 2 alcohol dehydrogenases affect hydride transfer and coenzyme dissociation rate constants. J Biol Chem. 1993;268:892–899.
Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337:1705–1714.
Cordain L, Bryan ED, Melby CL, et al. Influence of moderate daily wine consumption on body weight regulation and metabolism in healthy free-living males. J Am Coll Nutr. 1997;16:134–139.
Watzl B, Bub A, Pretzer G, et al. Daily moderate amounts of red wine or alcohol have no effect on the immune system of healthy men. Eur J Clin Nutr. 2004;58:40–45.
Xu YL, Carr LG, Bosron WF, et al. Genotyping of human alcohol dehydrogenases at the ADH2 and ADH3 loci following DNA sequence amplification. Genomics. 1988;2:209–214.
He TC, Zhou S, da Costa LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 1998;95:2509–2514.
Crow KE, Cornell NW, Veech RL . The rate of ethanol metabolism in isolated rat hepatocytes. Alcohol Clin Exp Res. 1977;1:43–50.
Philpott GW, Bower RJ, Parker CW . Selective iodination and cytotoxicity of tumor cells with an antibody–enzyme conjugate. Surgery. 1973;74:51–58.
Ganey PE, Thurman RG . Ethanol potentiates doxorubicin-induced inhibition of cell survival in cultured Chinese hamster ovary cells. Cancer Res. 1991;51:2036–2040.
Couch DB, Baker RC . Ethanol-enhanced cytotoxicity of alkylating agents. Alcohol Clin Exp Res. 2002;26:381–385.
Buttgereit P, Weineck S, Ropke G, et al. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection. Cancer Gene Ther. 2000;7:1145–1155.
Meskar A, Holownia A, Bardou LG, et al. Effect of acetaldehyde generated from ethanol by ADH-transfected CHO cells on their membrane fatty acid profiles. Alcohol. 1996;13:611–616.
Walia AS, Pruitt KM, Dillehay DL, et al. In vitro effect of acetaldehyde on cell-mediated cytotoxicity by murine spleen cells. Alcohol Clin Exp Res. 1989;13:766–771.
Abel EL . Behavioral teratology of alcohol (animal model studies of the fetal alcohol syndrome). In: Abel EL, ed. Fetal Alcohol Syndrome, Vol III. Animal Studies. Boca Raton, FL: CRC Press; 1982: 59–81.
Faulkner TP, Cantleberry SB, Watts VJ, Hussain AS . Comparative pharmacokinetics of ethanol in inbred strains of mice using doses based on total body water. Alcohol Clin Exp Res. 1990;14:82–86.
Livy DJ, Parnell SE, West JR . Blood ethanol concentration profiles: a comparison between rats and mice. Alcohol. 2003;29:165–171.
Johnsen J, Stowell A, Morland J . Clinical responses in relation to blood acetaldehyde levels. Pharmacol Toxicol. 1992;70:41–45.
Jones AW, Neiman J, Hillbom M . Concentration–time profiles of ethanol and acetaldehyde in human volunteers treated with the alcohol-sensitizing drug, calcium carbimide. Br J Clin Pharmacol. 1988;25:213–221.
Willis MS, Klassen LW, Tuma DJ, et al. Adduction of soluble proteins with malondialdehyde–acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcohol Clin Exp Res. 2002;26:94–106.
Willis MS, Thiele GM, Tuma DJ, et al. T cell proliferative responses to malondialdehyde–acetaldehyde haptenated protein are scavenger receptor mediated. Int Immunopharmacol. 2003;3:1381–1399.
Stewart SF, Vidali M, Day CP, et al. Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease. Hepatology. 2004;39:197–203.
Curiel DT . Strategies to adapt adenoviral vectors for targeted delivery. Ann NY Acad Sci. 1999;886:158–171.
Majumdar AS, Hughes DE, Lichtsteiner SP, et al. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters. Gene Therapy. 2001;8:568–578.
Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2003;53:268–291.
Acknowledgements
Thanks to Del Watling, Sandra Peak and colleagues at CRUK Clare Hall for technical support and to the late Leslie Warfield for her support and enthusiasm for this project. This work was supported by a generous donation from the organizers of the Caerphilly Megaday in memory of Andrew Nicholls and Paul Graeme.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Savage, P., Cowburn, P., Clemens, D. et al. Suicide gene therapy: conversion of ethanol to acetaldehyde mediated by human beta 2 alcohol dehydrogenase. Cancer Gene Ther 11, 774–781 (2004). https://doi.org/10.1038/sj.cgt.7700764
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700764